Noccioli Paolo, Grossi Simona, Tavoletta Saveria, Daulerio Alberto, Cianchetti Ettore
UO Senologia Chirurgica, PO G. Bernabeo - Ortona, Chieti.
Chir Ital. 2005 May-Jun;57(3):323-9.
Primary non-Hodgkin's lymphoma of the breast accounts for fewer than 3% of extranodal lymphomas. As compared to extranodal lymphomas in other sites they are characterised by more rapid progression and a worse prognosis. The aim of the study was to investigate 5 cases of primary lymphoma of the breast and review previous studies in a search for any preoperative characteristics that could assist in the management of lymphoma of the breast. All patients (n = 5) who were diagnosed with lymphomatous involvement of the breast between 1996 and 2004 were evaluated retrospectively. All patients staged IE (breast involvement only) or IIE (limited to the breast and ipsilateral armpit) were included. Most of the primary breast lymphomas were of intermediate grade. Patients received some combination of surgery, radiation, and chemotherapy. The mean follow-up was 48 months (range 24 to 72 months). All 5 patients survived at least 6 years from the time of diagnosis. Long-term survival in patients with primary non-Hodgkin's lymphoma of the breast is possible. The clinical outcome of patients with breast lymphoma depends on the histology and appears to parallel that of patients with lymphoma of similar histology involving other sites.
原发性乳腺非霍奇金淋巴瘤占结外淋巴瘤的比例不到3%。与其他部位的结外淋巴瘤相比,其特点是进展更快、预后更差。本研究的目的是调查5例原发性乳腺淋巴瘤病例,并回顾既往研究,以寻找有助于乳腺淋巴瘤治疗的术前特征。对1996年至2004年间诊断为乳腺淋巴瘤累及的所有患者(n = 5)进行回顾性评估。所有分期为IE期(仅乳腺受累)或IIE期(局限于乳腺及同侧腋窝)的患者均纳入研究。大多数原发性乳腺淋巴瘤为中级。患者接受了手术、放疗和化疗的某种联合治疗。平均随访时间为48个月(范围24至72个月)。所有5例患者自诊断后至少存活6年。原发性乳腺非霍奇金淋巴瘤患者有可能长期存活。乳腺淋巴瘤患者的临床结局取决于组织学类型,似乎与累及其他部位的类似组织学类型淋巴瘤患者的结局相似。